Table 1.
SARS-CoV-2–Positive (n = 179) | SARS-CoV-2–Negative With Close Contact (Asymptomatic) (n = 203) |
SARS-CoV-2–Negative With Clinical Suspicion (Symptomatic) (n = 121) |
P Value | |
---|---|---|---|---|
Age, y, mean±SD | 85.6 ± 8.2 | 83.5 ± 9.0 | 84.8 ± 8.8 | .05 |
Sex, female, n (%) | 135 (75.4) | 156 (76.9) | 91 (75.2) | .93 |
Smoking status, n (%) | .54 | |||
Current smoker | 1 (1.5) | 3 (3.5) | 5 (5.3) | |
Ex-smoker | 14 (20.3) | 11 (12.9) | 16 (16.8) | |
Nonsmoker | 54 (78.3) | 71 (83.5) | 74 (77.9) | |
Chronic diseases, n (%)‡ | ||||
Arterial hypertension | 82 (46.6) | 127 (76.5) | 91 (75.2) | <.001 |
Cardiomyopathy∗ | 75 (42.4) | 24 (27.0) | 64 (53.8) | <.001 |
Atrial fibrillation | 6 (6.1) | 7 (8.9) | 16 (14.7) | .11 |
Central and peripheral arterial disease | 68 (38.9) | 12 (13.3) | 17 (14.3) | <.001 |
Cardiac failure | 13 (10.6) | 13 (16.1) | 16 (14.6) | .48 |
Stroke | 30 (24.4) | 9 (11.0) | 18 (16.5) | .044 |
Diabetes (type 1 or 2) | 47 (27.2) | 40 (37.7) | 32 (26.7) | .12 |
Depression | 65 (31.4) | 47 (42.7) | 35 (29.7) | .07 |
Osteoarthrosis | 66 (54.1) | 21 (25.6) | 71 (67.0) | <.001 |
COPD† | 26 (15.1) | 22 (23.2) | 26 (21.9) | .187 |
Chronic renal failure | 16 (9.2) | 6 (6.9) | 23 (19.8) | .006 |
Chronic liver disease | 10 (5.7) | 9 (10.3) | 3 (2.5) | .06 |
Obesity | 14 (12.0) | 4 (5.4) | 17 (15.7) | .10 |
Poor nutritional status | 33 (28.0) | 2 (2.7) | 42 (38.5) | <.001 |
Psychiatric disorders | 46 (43.0) | 77 (48.1) | 55 (51.4) | .46 |
Nervous system disorders | 73 (68.2) | 42 (26.4) | 62 (56.9) | <.001 |
Dementia or cognitive impairment | 45 (42.5) | 10 (6.3) | 35 (33.0) | <.001 |
Total number of chronic diseases, median (Q1, Q3) | 3 (2, 5) | 2 (1, 3) | 5 (3, 6) | .002 |
Chronic diseases, n (%) | <.001 | |||
0, 1, 2 | 20 (11.2) | 76 (37.4) | 1 (0.8) | |
3+ | 159 (88.8) | 127 (62.6) | 120 (99.2) |
Q1, quartile 1; Q3, quartile 3; SD, standard deviation.
Ischemic, valvulopathy, or arrhythmia.
Or other bronchopneumopathies.
Information before COVID-19 incidence.